```html

Rotaviral Gastroenteritis – A Comprehensive Medical Guide

Overview

Rotaviral gastroenteritis, often simply called “rotavirus infection,” is an acute inflammation of the stomach and intestines caused by the rotavirus family of double‑stranded RNA viruses. It is the leading cause of severe, dehydrating diarrhea in infants and young children worldwide.

• Typical age group: 6 months – 3 years, with peak incidence at 12‑18 months.
• Global burden: Before the introduction of rotavirus vaccines, the virus accounted for an estimated 215 million episodes of diarrhea each year, resulting in ~197 000 deaths among children <5 years old, especially in low‑income countries (World Health Organization, 2023).
• Incidence in the United States: ≈55 000 hospitalizations and 20 000 emergency‑department visits annually despite high vaccine coverage (CDC, 2022).
• Seasonality: Peaks in late winter and early spring in temperate climates; year‑round in tropical regions.

Symptoms

The clinical picture usually begins 1–3 days after exposure (incubation period) and lasts 3–8 days. Symptoms can range from mild to severe and may include:

Symptom	Description
Watery diarrhea	Frequent, large‑volume stools that are pale or yellow‑green; can be >10 episodes/24 h in severe cases.
Vomiting	Sudden onset, often preceding diarrhea; may be projectile in infants.
Fever	Low‑grade (≤38.5 °C) to high (≥39 °C); usually peaks with the first 24‑48 h.
Abdominal cramps	Colicky pain that may cause a child to pull up their legs.
Loss of appetite	Common during the first 24‑48 h; improves as hydration returns.
Dehydration signs	Dry mouth, decreased tears, sunken fontanelle (infants), oliguria, lethargy, weight loss.
Irritability / lethargy	Result of fluid loss and electrolyte imbalance.
Sunken eyes	Indicator of moderate to severe dehydration.

Adults infected with rotavirus often experience milder gastrointestinal upset—usually brief diarrhea and nausea—because they have pre‑existing immunity from childhood exposure.

Causes and Risk Factors

What Causes Rotaviral Gastroenteritis?

Rotavirus is transmitted primarily via the fecal‑oral route. The virus is highly stable in the environment and can survive on hands, toys, surfaces, and in water for weeks.

• Person‑to‑person spread: Direct contact with an infected child’s stool or vomitus.
• Contaminated objects (fomites): Diapers, toys, bedding, bathroom fixtures.
• Food and water: Rare in high‑income settings but documented in outbreaks linked to contaminated food.

Risk Factors

• Age: Children <5 years, especially <2 years.
• Unvaccinated or incompletely vaccinated status: The two‑dose (RotaTeq) or three‑dose (Rotarix) schedule offers >85 % protection against severe disease.
• Day‑care attendance: Close contact with many children increases exposure.
• Living in crowded or low‑sanitation environments: Higher viral load in the environment.
• Immunocompromised state: Premature infants, children with HIV, or those on chemotherapy may have prolonged infection.

Diagnosis

Diagnosis is primarily clinical, based on the classic presentation of acute watery diarrhea and vomiting in a child of appropriate age. Laboratory testing is reserved for atypical cases, outbreak investigations, or when another pathogen must be ruled out.

Tests Used

• Stool antigen detection (enzyme immunoassay, EIA): Rapid, inexpensive, sensitivity ≈ 90 %.
• Reverse transcription polymerase chain reaction (RT‑PCR): Gold‑standard for research and outbreak typing; detects low viral loads.
• Complete blood count (CBC) and electrolytes: Not diagnostic for rotavirus but essential to assess dehydration and electrolyte disturbances.
• Blood gas analysis: In severe cases to evaluate metabolic acidosis.

Routine imaging (e.g., abdominal X‑ray) is not indicated unless there is concern for an alternative diagnosis such as intussusception.

Treatment Options

There is no antiviral medication that directly targets rotavirus. Management focuses on supportive care and prevention of dehydration.

Rehydration

• Oral rehydration solution (ORS): First‑line therapy; 20–30 mL/kg per hour in the first 4 h for mild‑moderate dehydration (WHO ORS formula). Continue offering small, frequent sips.
• Intravenous fluids: Indicated for severe dehydration, persistent vomiting, or inability to tolerate ORS. Typical regimen: 20 mL/kg isotonic saline bolus, repeat as needed.

Medications

• Antiemetics: Ondansetron (0.15 mg/kg orally) may be used in children who cannot retain ORS.
• Antidiarrheals: Not recommended for infants and young children; may prolong infection.
• Probiotics: Strains such as Lactobacillus rhamnosus GG or Saccharomyces boulardii can reduce duration by ~1 day (Cochrane review, 2020).

Adjunctive Measures

• Zinc supplementation: 20 mg daily for 10–14 days (10 mg for infants <6 months) shortens diarrhea duration in low‑resource settings (WHO, 2022).
• Continued feeding: Breast‑milk or age‑appropriate diet should be maintained; it does not worsen diarrhea and helps maintain nutrient intake.

Living with Rotaviral Gastroenteritis

Even after the acute phase, families can take steps to support recovery and prevent spreading the virus.

Daily Management Tips

1. Frequent hand washing: Use soap and warm water for at least 20 seconds after diaper changes, bathroom use, and before eating.
2. Clean contaminated surfaces: Disinfect toys, countertops, and bathroom fixtures with a bleach solution (1 part 5.25% bleach to 9 parts water).
3. Maintain hydration: Offer ORS or diluted juice after each loose stool or vomiting episode.
4. Monitor stool output: Keep a log of frequency, volume, and presence of blood or mucus; report changes to a clinician.
5. Watch weight: A loss of >5 % of body weight signals moderate dehydration.
6. Separate the sick child: If multiple children are in the household, keep the infected child away from others while symptomatic.

When to Return to Normal Activities

• Fever < 38 °C for 24 h without antipyretics.
• Stools are formed or substantially reduced in volume.
• Child is alert, drinking fluids well, and gaining weight.

Prevention

Vaccination is the cornerstone of rotavirus control, complemented by basic hygiene practices.

Vaccination

• RotaTeq (RV5): 3‑dose series at 2, 4, and 6 months.
• Rotarix (RV1): 2‑dose series at 2 and 4 months.
• Both vaccines are >85 % effective against severe gastroenteritis and have reduced hospitalizations by >90 % in countries with high coverage (CDC, 2022).

Hygiene Measures

• Handwashing with soap after diaper changes and before feeding.
• Proper disposal of diapers; seal in a closed bin.
• Cleaning of toys with hot, soapy water daily.
• Avoid sharing of utensils, cups, or bottles during outbreaks.

Complications

While most children recover uneventfully, untreated rotavirus can lead to serious outcomes:

• Severe dehydration: May require ICU admission, especially in infants <6 months.
• Electrolyte abnormalities: Hyponatremia, hypokalemia, metabolic acidosis.
• Secondary bacterial infection: Rare, but possible if mucosal barrier is compromised.
• Intussusception: A rare (1–5 per 100 000) but serious bowel obstruction that has been reported within 7 days after the first dose of rotavirus vaccine; symptoms include severe abdominal pain and “currant‑jelly” stools.
• Growth faltering: Repeated episodes of diarrhea in early life can impact weight and height trajectories.

When to Seek Emergency Care

References

• World Health Organization. Rotavirus vaccines: WHO position paper, January 2023. WHO; 2023.
• Centers for Disease Control and Prevention. Rotavirus Surveillance Data, 2022. CDC; 2022.
• Mayo Clinic. Rotavirus infection. 2024. https://www.mayoclinic.org/diseases‑conditions/rotavirus
• Cochrane Database of Systematic Reviews. Probiotics for treating acute infectious diarrhoea. 2020.
• Nelson Textbook of Pediatrics, 21st ed. Chapter on Gastroenteritis, 2023.
• American Academy of Pediatrics. Management of Acute Gastroenteritis in Children. 2023.

```